RBC Capital Maintains Sector Perform on Gilead Sciences, Raises Price Target to $84
Portfolio Pulse from richadhand@benzinga.com
RBC Capital analyst Brian Abrahams has maintained a 'Sector Perform' rating on Gilead Sciences (NASDAQ:GILD) and raised the price target from $83 to $84.

August 04, 2023 | 3:43 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
RBC Capital has maintained its 'Sector Perform' rating on Gilead Sciences and raised the price target from $83 to $84.
The news is directly related to Gilead Sciences. The 'Sector Perform' rating indicates that the analyst expects the company's stock to perform in line with the sector average. The slight increase in price target could be seen as a positive signal, but it's not significant enough to suggest a strong upward movement in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100